Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patients

被引：0
|
作者：
Alfonso De Stefano
Chiara Carlomagno
Stefano Pepe
Roberto Bianco
Sabino De Placido
机构：
[1] Università degli Studi di Napoli Federico II,Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Bevacizumab; Arterial hypertension; Metastatic colorectal cancer; Predictive marker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1207 / 1213
页数：6
相关论文
共 50 条
  • [41] Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
    P Österlund
    L-M Soveri
    H Isoniemi
    T Poussa
    T Alanko
    P Bono
    British Journal of Cancer, 2011, 104 : 599 - 604
  • [42] Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
    Oesterlund, P.
    Soveri, L. -M
    Isoniemi, H.
    Poussa, T.
    Alanko, T.
    Bono, P.
    BRITISH JOURNAL OF CANCER, 2011, 104 (04) : 599 - 604
  • [43] Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer
    Feliu, Jaime
    Salud, Antonieta
    Safont, Maria J.
    Garcia-Giron, Carlos
    Aparicio, Jorge
    Losa, Ferran
    Bosch, Carlos
    Escudero, Pilar
    Casado, Enrique
    Jorge, Monica
    Bohn, Uriel
    Perez-Carrion, Ramon
    Carmona, Alberto
    Custodio, Ana B.
    Maurel, Joan
    PLOS ONE, 2015, 10 (01):
  • [44] Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: updated results from a retrospective matched-pair analysis
    Gampenrieder, S. P.
    Romeder, F.
    Muss, C.
    Pircher, M.
    Ressler, S.
    Rinnerthaler, G.
    Bartsch, R.
    Sattlberger, C.
    Mlineritsch, B.
    Greil, R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S417 - S418
  • [45] RETRACTED: Association between bevacizumab-related chemotherapy regimens and serum vascular endothelial growth factor-A165b level in patients with metastatic colorectal cancer (Retracted Article)
    Xu, L.
    Chi, C.
    Wang, C.
    Zhang, L. M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (18) : 2687 - 2692
  • [46] Sex as a predictive factor in metastatic colorectal cancer treated with bevacizumab containing chemotherapy
    Jeong, Jae-Heon
    Baek, Sun Kyung
    Chae, Jung Min
    Lee, Gil Yeon
    Park, Sun Jin
    Kim, Si-Young
    Yoon, Hwi Joong
    Cho, Kyung Sam
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] BEVACIZUMAB RELATED ADVERSE EVENTS IN PATIENTS AFFECTED BY METASTATIC COLORECTAL CANCER: A META-ANALYSIS
    Cinquini, Michela
    Galfrascoli, Elena
    Rossi, Antonio
    Manazza, Andrea
    Damia, Giovanna
    Banna, Giuseppe
    Tosoni, Alicia
    Tiseo, Marcello
    Farina, Gabriella
    Garassino, Marina Chiara
    ANNALS OF ONCOLOGY, 2009, 20
  • [48] Bevacizumab related adverse events in patients affected by metastatic colorectal cancer: a meta-analysis
    Galfrascoli, Elena
    Garassino, Marina C.
    Cinquini, Michela
    Rossi, Antonio
    Manazza, Andrea
    Damia, Giovanna
    Farina, Gabriella
    Muserra, Gaetana
    PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 239 - 239
  • [49] Bevacizumab related adverse events in patients affected by metastatic colorectal cancer: a meta-analysis
    Galfrascoli, E.
    Cinquini, M.
    Rossi, A.
    Manazza, A.
    Damia, G.
    Banna, G.
    Tosoni, A.
    Tiseo, M.
    Farina, G.
    Garassino, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 343 - 343
  • [50] Efficacy and Safety of Bevacizumab in Chinese Patients with Metastatic Colorectal Cancer
    Zhu, Li-Ming
    Zhao, Ya-Zhen
    Ju, Hai-Xing
    Liu, Lu-Ying
    Chen, Lei
    Liu, Bi-Xia
    Xu, Qi
    Luo, Cong
    Ying, Jie-Er
    Yang, Yun-Shan
    Zhong, Hai-Jun
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (16) : 6559 - 6564
12345